BTI

BTI
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $12.069B ▼ | $5.019B ▼ | $4.512B ▲ | 37.385% ▲ | $2.05 ▲ | $6.194B ▲ |
| Q4-2024 | $13.527B ▲ | $12.777B ▲ | $-1.424B ▼ | -10.527% ▼ | $-0.66 ▼ | $1.855B ▼ |
| Q2-2024 | $12.34B ▼ | $5.918B ▼ | $4.492B ▲ | 36.402% ▲ | $2 ▲ | $5.882B ▼ |
| Q4-2023 | $13.842B ▲ | $32.881B ▲ | $-18.326B ▼ | -132.394% ▼ | $-8.23 ▼ | $6.751B ▲ |
| Q2-2023 | $13.441B | $5.262B | $3.959B | 29.455% | $1.77 | $6.418B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $4.893B ▼ | $110.226B ▼ | $63.049B ▼ | $46.874B ▼ |
| Q4-2024 | $5.81B ▼ | $118.899B ▼ | $68.904B ▲ | $49.643B ▼ |
| Q2-2024 | $6.63B ▲ | $119.369B ▲ | $64.9B ▼ | $54.111B ▲ |
| Q4-2023 | $2.964B ▼ | $118.716B ▼ | $65.782B ▼ | $52.566B ▼ |
| Q2-2023 | $4.132B | $146.072B | $73.444B | $72.298B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $4.512B ▲ | $2.309B ▼ | $1.012B ▲ | $-4.117B ▲ | $4.164B ▲ | $2.206B ▼ |
| Q4-2024 | $-1.424B ▼ | $3.48B ▲ | $-58M ▼ | $-7.274B ▼ | $-830M ▼ | $6.468B ▲ |
| Q2-2024 | $4.492B ▲ | $3.165B ▼ | $2.698B ▲ | $-3.358B ▲ | $5.694B ▲ | $3.049B ▼ |
| Q4-2023 | $-14.189B ▼ | $7.339B ▲ | $-337M ▼ | $-6.291B ▼ | $978M ▲ | $6.989B ▲ |
| Q2-2023 | $3.959B | $3.375B | $41M | $-3.023B | $235M | $3.265B |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, BTI looks like a mature, cash‑rich tobacco company in the middle of a difficult but necessary transition. The legacy cigarette business still throws off strong margins and reliable cash flow, but reported earnings have been noisy because of large write‑downs and the reshaping of the portfolio. The balance sheet carries meaningful debt yet remains manageable thanks to the strength of cash generation. Strategically, BTI enjoys a deep moat in its traditional brands and distribution and is leveraging that position to push hard into vaping, heated tobacco, and oral nicotine, backed by real R&D investment. The key opportunity is to replace declining combustible revenues with a growing, more sustainable smokeless portfolio; the key risks lie in regulation, execution in new categories, competition from other global players, and the pace at which consumers actually switch. The story is less about rapid growth and more about whether BTI can successfully and safely evolve a very profitable but structurally challenged business model over the next decade.
About British American Tobacco p.l.c.
https://www.bat.comBritish American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $12.069B ▼ | $5.019B ▼ | $4.512B ▲ | 37.385% ▲ | $2.05 ▲ | $6.194B ▲ |
| Q4-2024 | $13.527B ▲ | $12.777B ▲ | $-1.424B ▼ | -10.527% ▼ | $-0.66 ▼ | $1.855B ▼ |
| Q2-2024 | $12.34B ▼ | $5.918B ▼ | $4.492B ▲ | 36.402% ▲ | $2 ▲ | $5.882B ▼ |
| Q4-2023 | $13.842B ▲ | $32.881B ▲ | $-18.326B ▼ | -132.394% ▼ | $-8.23 ▼ | $6.751B ▲ |
| Q2-2023 | $13.441B | $5.262B | $3.959B | 29.455% | $1.77 | $6.418B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $4.893B ▼ | $110.226B ▼ | $63.049B ▼ | $46.874B ▼ |
| Q4-2024 | $5.81B ▼ | $118.899B ▼ | $68.904B ▲ | $49.643B ▼ |
| Q2-2024 | $6.63B ▲ | $119.369B ▲ | $64.9B ▼ | $54.111B ▲ |
| Q4-2023 | $2.964B ▼ | $118.716B ▼ | $65.782B ▼ | $52.566B ▼ |
| Q2-2023 | $4.132B | $146.072B | $73.444B | $72.298B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $4.512B ▲ | $2.309B ▼ | $1.012B ▲ | $-4.117B ▲ | $4.164B ▲ | $2.206B ▼ |
| Q4-2024 | $-1.424B ▼ | $3.48B ▲ | $-58M ▼ | $-7.274B ▼ | $-830M ▼ | $6.468B ▲ |
| Q2-2024 | $4.492B ▲ | $3.165B ▼ | $2.698B ▲ | $-3.358B ▲ | $5.694B ▲ | $3.049B ▼ |
| Q4-2023 | $-14.189B ▼ | $7.339B ▲ | $-337M ▼ | $-6.291B ▼ | $978M ▲ | $6.989B ▲ |
| Q2-2023 | $3.959B | $3.375B | $41M | $-3.023B | $235M | $3.265B |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, BTI looks like a mature, cash‑rich tobacco company in the middle of a difficult but necessary transition. The legacy cigarette business still throws off strong margins and reliable cash flow, but reported earnings have been noisy because of large write‑downs and the reshaping of the portfolio. The balance sheet carries meaningful debt yet remains manageable thanks to the strength of cash generation. Strategically, BTI enjoys a deep moat in its traditional brands and distribution and is leveraging that position to push hard into vaping, heated tobacco, and oral nicotine, backed by real R&D investment. The key opportunity is to replace declining combustible revenues with a growing, more sustainable smokeless portfolio; the key risks lie in regulation, execution in new categories, competition from other global players, and the pace at which consumers actually switch. The story is less about rapid growth and more about whether BTI can successfully and safely evolve a very profitable but structurally challenged business model over the next decade.

CEO
Tadeu Luiz Marroco
Compensation Summary
(Year 2024)

CEO
Tadeu Luiz Marroco
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2017-02-14 | Forward | 2:1 |
| 2017-02-02 | Forward | 2:1 |
| 1998-09-08 | Reverse | 1:2 |
| 1994-03-15 | Reverse | 1:2 |
| 1993-05-27 | Forward | 2:1 |
| 1983-06-20 | Forward | 4:1 |
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

CAPITAL INTERNATIONAL INVESTORS
64.057M Shares
$3.758B

GQG PARTNERS LLC
28.555M Shares
$1.675B

CAPITAL RESEARCH GLOBAL INVESTORS
22.069M Shares
$1.295B

FMR LLC
20.42M Shares
$1.198B

BLACKROCK INC.
20.048M Shares
$1.176B

BLACKROCK, INC.
10.894M Shares
$639.017M

ORBIS ALLAN GRAY LTD
9.521M Shares
$558.509M

CAPITAL WORLD INVESTORS
9.471M Shares
$555.552M

BANK OF AMERICA CORP /DE/
6.935M Shares
$406.795M

EVERCORE TRUST COMPANY, N.A.
5.301M Shares
$310.947M

MORGAN STANLEY
5.264M Shares
$308.813M

RAYMOND JAMES & ASSOCIATES
4.36M Shares
$255.73M

MONDRIAN INVESTMENT PARTNERS LTD
4.186M Shares
$245.528M

FEDERATED HERMES, INC.
3.779M Shares
$221.684M

BRIDGEWATER ASSOCIATES, LP
3.743M Shares
$219.548M

WELLS FARGO & COMPANY/MN
3.591M Shares
$210.668M

GOLDMAN SACHS GROUP INC
3.334M Shares
$195.576M

NATIXIS ADVISORS, L.P.
3.102M Shares
$181.952M

ENVESTNET ASSET MANAGEMENT INC
3.024M Shares
$177.383M

RAYMOND JAMES FINANCIAL INC
2.853M Shares
$167.344M
Summary
Only Showing The Top 20




